Keyphrases
Chemotherapy
100%
Small Interfering RNA (siRNA)
100%
Nanocarriers
100%
RNA Interference
100%
Co-delivery
100%
Drug Resistance
100%
Drug-resistant Cancer
100%
Tumor Cells
40%
Apoptosis Inhibition
40%
Drug Type
40%
Drug Resistance mutations
40%
Synergistic Effect
20%
High-level Expression
20%
B-cell Lymphoma 2 (Bcl-2)
20%
DNA Damage
20%
Drug Release
20%
Gene Silencing
20%
Anti-apoptotic Proteins
20%
ATP-binding Cassette Transporter A1 (ABCA1)
20%
Release Kinetics
20%
Cellular Uptake
20%
Cell Cycle Checkpoint
20%
Genetic Basis
20%
Drug Treatment
20%
Multidrug Resistance Protein 1 (MDR1)
20%
Resistance Response
20%
Cell Concentration
20%
P-glycoprotein (P-gp)
20%
Multidrug Resistance
20%
Drug Target
20%
Transporter Proteins
20%
Drug-resistant Tumor
20%
Metabolic Alterations
20%
Efflux Pump
20%
Environmental Cues
20%
Resistance Phenotypes
20%
Membrane Lipids
20%
Chemotherapeutic Treatment
20%
ATP Binding Cassette Subfamily B Member 1 (ABCB1)
20%
Rapid Drug Release
20%
Gene Inhibition
20%
Carrier Polymer
20%
Abnormal Gene Expression
20%
Drug Resistance Protein
20%
Drug Inhibition
20%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Chemotherapy
100%
Nanocarrier
100%
Drug Resistance
100%
Small Interfering RNA
83%
Antiinfective Agent
50%
Multidrug Resistance Protein 1
50%
Neoplasm
33%
Drug Release
33%
Effusion
16%
Antiapoptotic
16%
Prematurity
16%
Carrier Protein
16%
ABC Transporter
16%
Pharmacotherapy
16%
P-Glycoprotein
16%
Membrane Lipid
16%
Polymer Carrier
16%
Biochemistry, Genetics and Molecular Biology
RNA Interference
100%
Drug Resistance
100%
Small Interfering RNA
83%
P Glycoprotein 1
33%
Gene Expression
16%
Membrane Lipid
16%
Cross-Link
16%
ABC Transporter
16%
Genetics
16%
Bcl-2
16%
Cell Cycle Checkpoint
16%
ATP-binding Cassette Transporter
16%
P-Glycoprotein
16%
Drug Inhibition
16%
Gene Inactivation
16%
Carrier Protein
16%